News

August 2, 2016August 2, 2016

Specific Laser Prostate Procedure Is Safe BPH Treatment in Elderly, Researchers Say

News

Holmium laser enucleation of the prostate (HoLEP) is an increasingly used safe and effective alternative for the management of benign prostatic hyperplasia (BPH). Researchers studied the outcomes of this treatment ... Read more

August 1, 2016

B-TURP for BPH in Larger Prostates is Preferred Treatment by Surgeons, According to Study from India

News

Researchers compared the outcomes of two surgical approaches to treat bladder obstruction due to benign prostatic hyperplasia (BPH). The findings reveal that, despite conflicting literature, bipolar transurethral resection of prostate (B-TURP) ... Read more

August 1, 2016

Questions to Ask Before Participating in BPH Clinical Trial

News

There are several key questions that any participant should ask, and have answered, before enrolling in a clinical trial. Many are listed here, but patients should feel free to ask study coordinators ... Read more

July 28, 2016July 28, 2016

Naftopidil Seen to Effectively Treat Benign Prostatic Hyperplasia Over Long Term

News

Recent research from Japan shows that treatment with naftopidil is effective in the long term for patients with benign prostatic hyperplasia. Older age, increased prostate volume, and elevated prostate-specific antigen at ... Read more

July 27, 2016August 1, 2016

Types of BPH Clinical Trials

News

The decision to enroll in a clinical trial should involve a discussion between the patient with benign prostatic hyperplasia (BPH) and his or her physician. Participation will depend on many factors, including ... Read more

July 26, 2016

Literature on Newer Drugs for LUTS Attributed to BPH Reviewed by Researchers

News

The U.S. Agency for Healthcare Research and Quality has published a review of the available evidence on the newer medicines for the treatment of lower urinary tract symptoms (LUTS) attributed ... Read more

July 25, 2016July 25, 2016

Duodart, a Fixed-Dose Combo Therapy for BPH, Found Most Cost Effective in Nigerian Study

News

A cost-effectiveness analysis of treatments for moderate to severe benign prostatic hyperplasia (BPH) in Nigeria, done from perspective of the social health service provider, favored the fixed-dose combination of dutasteride and tamsulosin therapy over dutasteride monotherapy. ... Read more

July 21, 2016July 21, 2016

LUTS in BPH Could Improve with Drugs that Target Bladder

News

While lower urinary tract symptoms (LUTS) in men are typically blamed on the enlargement of the prostate, a review from the University of Thessaly in Greece puts the spotlight on research showing ... Read more

July 20, 2016July 20, 2016

Androgen Receptor in Prostate Seen to Differ in BPH and Cancer Patients

News

Research into the role and frequency of the male sex androgen (hormone) receptor in three diseases involving the prostate — abnormal cell growth, benign prostatic hyperplasia (BPH), and cancer — found the receptor ... Read more

July 19, 2016

Functional Daily Ability and BPH Linked to Urinary Incontinence in Older Korean Men

News

Benign prostatic hyperplasia (BPH) is one of the risk factors for urinary incontinence (UI) in older men. Researchers at two Korean universities investigated the prevalence of urinary incontinence among older Korean men, ... Read more